Cost-effectiveness of ranibizumab for the treatment of neovascular age-related macular degeneration in germany: Model analysis from the perspective of germany's statutory health insurance system
Neubauer, Aljoscha S., MD, MBA, Holz, Frank G., MD, Sauer, Stefan, PhD, Wasmuth, Timo, MA, Hirneiss, Christoph, MD, Kampik, Anselm, MD, Schrader, Wolfgang, MD
Published in Clinical therapeutics (01.07.2010)
Published in Clinical therapeutics (01.07.2010)
Get full text
Journal Article